Covered recipient · General Payments record
MEGHANA BHATTA KUMAR
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2019–2024
$7,536.20
- Reported across 202 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $693.63 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BETA BIONICS, INC. | $397.78 | 3 |
| Novo Nordisk AS | $106.14 | 6 |
| Abbott Laboratories | $57.82 | 3 |
| Lilly USA, LLC | $51.30 | 2 |
| Radius Health, Inc. | $49.38 | 2 |
| Amgen Inc. | $16.50 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.90 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124812839 | CMS |
| Abbott Laboratories | $19.99 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124812841 | CMS |
| Abbott Laboratories | $18.93 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124812843 | CMS |
| Amgen Inc. | $16.50 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115835909 | CMS |
| BETA BIONICS, INC. | $108.85 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087873457 | CMS |
| BETA BIONICS, INC. | $146.59 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087881119 | CMS |
| BETA BIONICS, INC. | $142.34 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087888181 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.71 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117850615 | CMS |
| Lilly USA, LLC | $20.64 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135199599 | CMS |
| Lilly USA, LLC | $30.66 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135208145 | CMS |
| Novo Nordisk Inc | $15.04 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096715179 | CMS |
| Novo Nordisk Inc | $19.27 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097547583 | CMS |
| Novo Nordisk Inc | $18.50 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097235156 | CMS |
| Novo Nordisk Inc | $17.76 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096606815 | CMS |
| Novo Nordisk Inc | $20.24 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097722025 | CMS |
| Novo Nordisk Inc | $15.33 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096984699 | CMS |
| Radius Health, Inc. | $25.85 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089975176 | CMS |
| Radius Health, Inc. | $23.53 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089975182 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.